Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Qlucore Targets Academic and Commercial Biotech, Life Science Markets with Novo Newton Scientific Ltd

Published: Thursday, January 24, 2013
Last Updated: Thursday, January 24, 2013
Bookmark and Share
New alliance increases Qlucore's sales and marketing presence in Ireland, Spain, Italy and South Africa.

Qlucore has announced an agency agreement with Novo Newton Scientific Ltd. Novo Newton will assist in marketing Qlucore's Omics Explorer software in Ireland, Spain, Italy and South Africa. Recently Qlucore has also signed a distribution agreement in Japan, and raised investment finance for expansion into the US market.

Qlucore's intuitive software, Qlucore Omics Explorer, provides researchers with a world leading data analysis tool that is both extremely powerful and simple to use. Qlucore’s software is unique in that it allows researchers – the people with the most biological insight – to study their own data and to look for patterns and structures. Qlucore Omics Explorer is built on the premise that visualization is one of the key drivers for effective analysis of complex data in "big data" environments. As a result, researchers do not need to be statistics or computer experts in order to use Qlucore Omics Explorer effectively.

Carl-Johan Ivarsson, President, Qlucore says, "We are delighted that Novo Newton Scientific Ltd will be distributing our software into these territories. This will increase our market presence. We have been very impressed with the firm's professionalism and we are looking forward to working with the team."

Qlucore Omics Explorer is used in 19 countries by large pharmaceutical and biotech companies and renowned academic institutions. A list of scientific articles published referencing Qlucore can be found at http://www.qlucore.com/references.aspx

Tom Nugent , Chief Financial Officer , Novo Newton Scientific Ltd comments. “We are excited to collaborate with Qlucore and to be promoting Qlucore Omics Explorer. Qlucore is well respected in the scientific community and providing robust and reliable software that is well supported. The amount of genomic data is growing very quickly, and there is strong demand for high quality solutions such as Qlucore.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Qlucore, Nebion Collaborate
Partnership aims to address complementary use cases.
Friday, February 07, 2014
Using Qlucore Omics Explorer for Interpreting Leukemia Proteomics Data
Qlucore software has speeded up the process and enabled discovery for leukemia researcher Steven Kornblau.
Monday, November 18, 2013
New Research Aims to Stop ‘Blood Doping' During Cycling and Other Competitive Sports
As cyclists take to the roads of Surrey, England, the subject of blood doping raises its head once again.
Thursday, August 01, 2013
How it Works: Advanced Data Analysis Using Visualisation
Visualisation is a powerful tool for those working in molecular biology, here Qlucore offers a five-step method to ensure repeatable and significant results.
Monday, June 24, 2013
Qlucore Receives R&D Funding
VINNOVA Grant will speed the interactivity and visual feedback of Next Generation Sequencing (NGS) data analysis for scientists.
Monday, April 29, 2013
Researchers Develop Animal Free Methods for Testing Chemical Compounds for Allergens
EU-funded research project developing in vitro (‘out of body’) test strategies to reduce or replace animal testing use gene expression analysis software.
Monday, April 08, 2013
NHS Urged to Prepare for ‘Genetic Revolution’
The ability to bring biologists into the data analysis phase will be key to achieving this important goal.
Monday, November 21, 2011
Qlucore to Expand its Marketing Efforts with New High-profile Appointment to its Board
New appointment coincides with the injection of new capital to increase market activities of its data analysis tool
Wednesday, November 25, 2009
Scientific News
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!